FDA to Collect Patient Experience Data: Upcoming Guidance Documents Will Spell Out What and How to Submit

Lignende værker

• Compounding Pharmacists Unhappy With New FDA Guidance Documents: Rules Severely Limit Distribution
  af: Barlas, Stephen
  Udgivet: (2016)
• FDA Pleases No One With Final Guidance On Naming of Biologicals and Biosimilars
  af: Barlas, Stephen
  Udgivet: (2017)
• Pharmacists Welcome FDA’s Opioids REMS: How Directly Will They Be Affected?
  af: Barlas, Stephen
  Udgivet: (2012)
• Two Draft FDA Guidance Documents Stir Controversy: Hospital and 503B Pharmacy Repackaging and Compounding Are at Issue
  af: Barlas, Stephen
  Udgivet: (2015)
• FDA Finalizes Drug Communication Guidance: P&T Committees Can Receive Data Beyond the Drug Label
  af: Barlas, Stephen
  Udgivet: (2018)